Asterias Biotherapeutics: 3Q Earnings Snapshot
FREMONT, Calif. (AP) _ Asterias Biotherapeutics Inc. (AST) on Friday reported a loss of $4.5 million in its third quarter.
The Fremont, California-based company said it had a loss of 8 cents per share.
The stem cell therapy developer posted revenue of $116,000 in the period.
In the final minutes of trading on Friday, the company’s shares hit $1.30. A year ago, they were trading at $2.45.